These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32796442)

  • 41. Efficacy of Dexamethasone Implants in Uveitic Macular Edema in Cases with Behçet Disease.
    Yalcinbayir O; Caliskan E; Ucan Gunduz G; Gelisken O; Kaderli B; Yucel AA
    Ophthalmologica; 2019; 241(4):190-194. PubMed ID: 30244248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
    Ozdemir H; Karacorlu M; Karacorlu S
    Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
    Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
    Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
    Ozkaya A; Tarakcioglu HN; Tanir I
    Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.
    Fonollosa A; Zarranz-Ventura J; Valverde A; Becerra E; Bernal-Morales C; Pastor-Idoate S; Zapata MA
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
    Kim M; Kim SA; Park W; Kim RY; Park YH
    Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography.
    Makiyama Y; Oishi A; Otani A; Ogino K; Nakagawa S; Kurimoto M; Yoshimura N
    Retina; 2014 May; 34(5):981-8. PubMed ID: 24756036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
    Lee H; Kang KE; Chung H; Kim HC
    Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa.
    Melo GB; Farah ME; Aggio FB
    Acta Ophthalmol Scand; 2007 Jun; 85(4):461-3. PubMed ID: 17313405
    [No Abstract]   [Full Text] [Related]  

  • 52. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
    Zur D; Iglicki M; Sala-Puigdollers A; Chhablani J; Lupidi M; Fraser-Bell S; Mendes TS; Chaikitmongkol V; Cebeci Z; Dollberg D; Busch C; Invernizzi A; Habot-Wilner Z; Loewenstein A;
    Acta Ophthalmol; 2020 Mar; 98(2):e217-e223. PubMed ID: 31421028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema.
    Altintas AGK; Ilhan C
    Korean J Ophthalmol; 2019 Jun; 33(3):259-266. PubMed ID: 31179657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early Retinal and Choroidal Coat Thickness Changes after Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.
    Horozoğlu F; Sever Ö
    Balkan Med J; 2018 Sep; 35(5):384-387. PubMed ID: 29866639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa.
    Ruff A; Tezel A; Tezel TH
    PLoS One; 2022; 17(10):e0276629. PubMed ID: 36269735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
    Kaldırım H; Savur F; Kırgız A; Atalay K
    Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visual acuity and microperimetric mapping of lesion area in eyes with inflammatory cystoid macular oedema.
    Munk MR; Kiss CG; Huf W; Montuoro A; Sulzbacher F; Kroh M; Larsen M; Schmidt-Erfurth U
    Acta Ophthalmol; 2014 Jun; 92(4):332-8. PubMed ID: 23802743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: a case report.
    Sharma A; Madhusudhan RJ; Nadahalli V; Damgude SA; Sundaramoorthy SK
    Indian J Ophthalmol; 2012; 60(3):234-5. PubMed ID: 22569393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.